Takeda Pharmaceutical (TAK) Change in Acquisitions & Divestments (2018 - 2026)

Takeda Pharmaceutical has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $2.4 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 69.82% year-over-year to $2.4 million in Q2 2026; TTM through Jun 2026 was $203.0 million, a 20.36% increase from a year earlier, with the FY2026 full-year figure at $44.8 million, down 76.8% from the prior year.
• Change in Acquisitions & Divestments was $2.4 million for Q2 2026 at Takeda Pharmaceutical, down from $9.3 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $181.2 million in Q3 2025, with the low at $2.4 million in Q2 2026.
• Average Change in Acquisitions & Divestments over 5 years is $48.3 million, with a median of $20.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments surged 982.69% in 2022, then plunged 91.71% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $15.2 million in 2022, then sank by 79.67% to $3.1 million in 2023, then jumped by 656.39% to $23.4 million in 2024, then tumbled by 56.75% to $10.1 million in 2025, then slumped by 76.79% to $2.4 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $2.4 million (Q2 2026), $9.3 million (Q1 2026), and $10.1 million (Q4 2025), per Business Quant data.